ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,826.06
      0.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      10/02/20177:00AMGlobeNewswire Inc.uniQure Announces Company Presentations at Upcoming October ConferencesNASDAQ:QUREuniQure NV
      09/29/20174:11PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:QUREuniQure NV
      09/26/20175:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      09/26/20175:15PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:QUREuniQure NV
      09/22/20174:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      09/22/20174:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      09/22/20174:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      09/22/20174:33PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:QUREuniQure NV
      09/18/20174:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      09/18/20174:05PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:QUREuniQure NV
      09/14/201712:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      08/24/20177:00AMGlobeNewswireuniQure Announces Company Participation at Citi Healthcare ConferenceNASDAQ:QUREuniQure NV
      08/24/20177:00AMGlobeNewswire Inc.uniQure Announces Company Participation at Citi Healthcare ConferenceNASDAQ:QUREuniQure NV
      08/16/20174:39PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:QUREuniQure NV
      08/15/20174:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:QUREuniQure NV
      08/08/20175:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:QUREuniQure NV
      08/08/201710:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      08/08/20177:20AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:QUREuniQure NV
      08/08/20177:00AMGlobeNewswireuniQure Announces Second Quarter 2017 Financial Results and Recent Company ProgressNASDAQ:QUREuniQure NV
      08/08/20177:00AMGlobeNewswire Inc.uniQure Announces Second Quarter 2017 Financial Results and Recent Company ProgressNASDAQ:QUREuniQure NV
      08/07/201710:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      08/07/20177:00AMGlobeNewswireuniQure Announces Leadership Team Appointments and Nominations to its Board of DirectorsNASDAQ:QUREuniQure NV
      08/07/20177:00AMGlobeNewswire Inc.uniQure Announces Leadership Team Appointments and Nominations to its Board of DirectorsNASDAQ:QUREuniQure NV
      07/31/201710:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      07/31/20177:00AMGlobeNewswireuniQure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia BNASDAQ:QUREuniQure NV
      07/31/20177:00AMGlobeNewswire Inc.uniQure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia BNASDAQ:QUREuniQure NV
      07/21/20177:00AMGlobeNewswireuniQure Announces the Successful Development and Scale-up of Manufacturing Processes for Its Hemophilia B Gene Therapy ProgramNASDAQ:QUREuniQure NV
      07/21/20177:00AMGlobeNewswire Inc.uniQure Announces the Successful Development and Scale-up of Manufacturing Processes for Its Hemophilia B Gene Therapy Progra...NASDAQ:QUREuniQure NV
      07/18/20177:00AMGlobeNewswireuniQure Expands Intellectual Property Portfolio with Newly Issued Patent Providing Broad Protection of Insect Cell-Based AAV ...NASDAQ:QUREuniQure NV
      07/18/20177:00AMGlobeNewswire Inc.uniQure Expands Intellectual Property Portfolio with Newly Issued Patent Providing Broad Protection of Insect Cell-Based AAV ...NASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE